Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Summit Therapeutics Inc.

Get SEC filing alerts via email and in your feed for Summit Therapeutics Inc.

SMMT

Summit Therapeutics Inc.

Latest news & discussion for Summit Therapeutics Inc.:

1
1
Summit Therapeutics Inc. Summit Therapeutics Reports $62.9 Million Net Loss in Q1 2025, Expands License Agreement with Akeso

Via official filing (AI summary) | 4 days ago | 0 comments

2
1
Summit Therapeutics Inc. Summit Therapeutics Reports $221.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Summit Therapeutics Inc. Summit Therapeutics Reports Significant Asset Growth, Increased Losses Amid Ongoing Investment in Ivonescimab Clinical Trials

Via official filing (AI summary) | 6 months ago | 0 comments